Wegovy®
semaglutide
- Form
- Weekly injection; daily tablet
- Approved for
- Chronic weight management; reducing the risk of major cardiovascular events in adults with heart disease and obesity or overweight
Start with a secure online assessment. An independent, licensed clinician reviews it and, only if it's clinically appropriate, prescribes an FDA-approved, brand-name GLP-1 medication, filled by a state-licensed U.S. pharmacy. Follow-up care continues for as long as you're in the program.
The same order a careful clinic follows: understand your health first, consider medication only if it fits, and keep checking in.
Answer questions about your health history, current medications, and goals from home, through a secure intake.
An independent clinician licensed in your state reviews your answers and may ask for recent labs or a video visit.
If an FDA-approved GLP-1 medication is a good clinical fit, your clinician prescribes it. If not, they explain why.
A state-licensed U.S. pharmacy fills your prescription and ships it with the official Medication Guide.
Regular check-ins to see how you feel, help with side effects, and adjust your dose when appropriate.
Clinicians on the Oak77 Health platform prescribe only FDA-approved products. Whether one is right for you, and which, is a decision you make together with your clinician.
FDA-approved for adults with obesity, or with overweight and at least one weight-related condition, used alongside a reduced-calorie diet and increased physical activity.
semaglutide
tirzepatide (GIP/GLP-1)
liraglutide
orforglipron
FDA-approved to improve blood sugar control in adults with type 2 diabetes. These are prescribed only as part of type 2 diabetes care, never for weight management.
semaglutide
semaglutide
tirzepatide
dulaglutide
liraglutide
Prescription only, and only if clinically appropriate. Availability depends on your health history, your state, and pharmacy supply. Please review the Important Safety Information, including the boxed warning, and each product's full Prescribing Information and Medication Guide. Wegovy®, Ozempic®, Rybelsus®, Saxenda® and Victoza® are registered trademarks of Novo Nordisk A/S. Zepbound®, Mounjaro®, Trulicity® and Foundayo™ are trademarks of Eli Lilly and Company. Oak77 Health is not affiliated with or endorsed by these manufacturers.
Oak77 Health provides the telehealth platform and patient support. Oak77 Health does not practice medicine; all diagnosis, prescribing and treatment decisions are made by independent, licensed clinicians. Prescriptions are dispensed by state-licensed U.S. pharmacies.
Independent clinicians licensed in your state review your history, decide whether treatment fits, and own every prescribing decision.
Prescriptions are dispensed by state-licensed U.S. pharmacies, using FDA-approved, brand-name products.
Health details are collected through a secure intake and shared only with your treating clinician and dispensing pharmacy.
GLP-1 medications are approved for use with a reduced-calorie diet and more activity. We help with both, in realistic steps.
Weight-management GLP-1 medications are FDA-approved for adults who meet the criteria below. Your clinician decides eligibility after reviewing your full health history.
Adults with a body mass index (BMI) of 30 or higher.
Adults with a BMI of 27 or higher and at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol.
These reflect the FDA-approved labeling for weight-management products, used together with a reduced-calorie diet and increased physical activity. Meeting them does not mean a prescription will be written; your clinician determines eligibility.
A first prescription is a starting point, not a finish line. Follow-up care adjusts as your body and your routine change.
Yes. Every medication on this site is prescription-only. An independent, licensed clinician must review your health information and decide whether one is clinically appropriate for you.
Only FDA-approved, brand-name products, each for its approved use. For chronic weight management, clinicians may consider Wegovy®, Zepbound®, Saxenda® or Foundayo™. For type 2 diabetes care, they may consider Ozempic®, Rybelsus®, Mounjaro®, Trulicity® or Victoza®.
No. Ozempic®, Rybelsus®, Mounjaro®, Trulicity® and Victoza® are FDA-approved for type 2 diabetes, and they are prescribed only as part of type 2 diabetes care.
No. Prescriptions are written only when your clinician decides treatment is clinically appropriate. If it isn't, your clinician will explain why and talk through other options.
Coverage varies by plan. We can help check whether your pharmacy benefit covers a prescribed medication. Coverage decisions are made by your plan.
Yes. Health information is collected through a secure intake, handled under HIPAA-aligned safeguards, and shared only with your treating clinician and dispensing pharmacy to deliver your care. We never sell it.
Care is available in states where independent, licensed clinicians on the platform can see patients. Select your state when you get started and we'll confirm availability.
Start with a short, secure assessment. A licensed clinician will review it and walk you through your options, with no obligation.